ResMed reported $1.46B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Ansell USD 1.03B 192.2M Dec/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 154.45M 850K Sep/2026
Baxter International USD 2.98B 20M Sep/2026
Cochlear AUD 1.18B 590.35M Dec/2025
Cooper Companies USD 1.07B 15.3M Jun/2026
CSL USD 8.33B 4.79B Dec/2025
Dexcom USD 1.34B 30M Sep/2026
Edwards Lifesciences USD 1.72B 20M Sep/2026
Fisher Paykel Healthcare NZD 1.24B 137.8M Jun/2026
Globus Medical USD 763.72M 25.89M Sep/2026
Haemonetics USD 357.76M 18.76M Sep/2026
Idexx Laboratories USD 1.21B 10M Sep/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 842M 40.3M Sep/2026
Integra LifeSciences USD 411.18M 7.62M Sep/2026
Intuitive Surgical USD 3.05B 158.7M Sep/2026
Medtronic USD 9.8B 0 Jun/2026
Philips EUR 4.4B 40M Sep/2026
Ramsay Health Care AUD 9.24B 7.25B Dec/2026
ResMed USD 1.46B 60M Jun/2026
Sigma Healthcare AUD 1.68B 188.65M Dec/2024
Sonic Healthcare AUD 5.42B 30M Jun/2026
Steris USD 1.59B 88.6M Sep/2026
Teleflex USD 567.8M 2.5M Sep/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026